Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 983

1.

Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.

Guadalupe M, Sankaran S, George MD, Reay E, Verhoeven D, Shacklett BL, Flamm J, Wegelin J, Prindiville T, Dandekar S.

J Virol. 2006 Aug;80(16):8236-47.

3.

Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.

Jansen CA, De Cuyper IM, Steingrover R, Jurriaans S, Sankatsing SU, Prins JM, Lange JM, van Baarle D, Miedema F.

AIDS. 2005 Jul 22;19(11):1145-54.

PMID:
15990567
4.
6.

Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.

Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I.

Clin Infect Dis. 2008 Jun 15;46(12):1902-10. doi: 10.1086/588480.

7.

Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function.

Lange CG, Xu Z, Patterson BK, Medvik K, Harnisch B, Asaad R, Valdez H, Lee SJ, Landay A, Lieberman J, Lederman MM.

AIDS. 2004 Mar 5;18(4):605-13.

PMID:
15090765
8.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
9.

Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.

Pierdominici M, Giovannetti A, Ensoli F, Mazzetta F, Marziali M, De Cristofaro MR, Santini-Muratori D, Leti W, Aiuti F.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):122-31.

PMID:
11832680
10.

Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes.

Costa P, Rusconi S, Mavilio D, Fogli M, Murdaca G, Pende D, Mingari MC, Galli M, Moretta L, De Maria A.

AIDS. 2001 May 25;15(8):965-74.

PMID:
11399978
11.

CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.

Benito JM, Lopez M, Lozano S, Ballesteros C, Capa L, Martinez P, Gonzalez-Lahoz J, Soriano V.

J Infect Dis. 2005 Dec 15;192(12):2142-6.

12.

Immune reconstitution in the sigmoid colon after long-term HIV therapy.

Sheth PM, Chege D, Shin LY, Huibner S, Yue FY, Loutfy M, Halpenny R, Persad D, Kovacs C, Chun TW, Kandel G, Ostrowski M, Kaul R.

Mucosal Immunol. 2008 Sep;1(5):382-8. doi: 10.1038/mi.2008.23.

PMID:
19079202
13.
14.

Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.

Lacabaratz-Porret C, Urrutia A, Doisne JM, Goujard C, Deveau C, Dalod M, Meyer L, Rouzioux C, Delfraissy JF, Venet A, Sinet M.

J Infect Dis. 2003 Mar 1;187(5):748-57.

16.

Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination.

Imami N, Hardy G, Burton C, Pires A, Pido-Lopez J, Moss R, Gazzard B, Gotch F.

Immunol Lett. 2001 Nov 1;79(1-2):63-76.

PMID:
11595291
18.

Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.

Terzieva V, Popova D, Kicheva M, Todorova Y, Markova R, Martinova F, Elenkov I, Yankova M.

Int Immunopharmacol. 2009 Jul;9(7-8):831-6. doi: 10.1016/j.intimp.2009.03.009.

PMID:
19303058
19.

Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1.

Aries SP, Weyrich K, Schaaf B, Hansen F, Dennin RH, Dalhoff K.

Scand J Immunol. 1998 Jul;48(1):86-91.

20.

Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection.

Lascar RM, Lopes AR, Gilson RJ, Dunn C, Johnstone R, Copas A, Reignat S, Webster G, Bertoletti A, Maini MK.

J Infect Dis. 2005 Apr 1;191(7):1169-79.

Items per page

Supplemental Content

Support Center